Daniel Bejarano Quisoboni is a health economist interested in health services research using Real-World Data. He has worked on various pharmaco-epidemiology and clinical trial projects in Spain. In October 2019, he joined the radiation epidemiology team at INSERM's Centre de recherche en épidémiologie et santé des populations (CESP), where he conducted his PhD thesis (defended in 2023) on the economic burden of the long-term effects of childhood cancer treatments.
He is currently working as a post-doctoral fellow in the Primary Care and Prevention team at CESP, in the multidisciplinary TraGenInnov project, analyzing the trajectories of genetic test prescription and performance in France, based on data from the French National Health Data System (SNDS).
